| Identification | Back Directory | [Name]
buddlejasaponin IV | [CAS]
139523-30-1 | [Synonyms]
Saikosaponin 1
buddlejasaponin IV
Buddleoglucoside IV
[(4R)-13,28-Epoxy-16β,23-dihydroxyolean-11-en-3β-yl]2-O,3-O-bis(β-D-glucopyranosyl)-6-deoxy-β-D-galactopyranoside
[(4R)-16β,23-Dihydroxy-13,28-epoxyoleana-11-ene-3β-yl]6-deoxy-2-O,3-O-bis(β-D-glucopyranosyl)-β-D-galactopyranoside
β-D-Galactopyranoside, (3β,4α,16β)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-6-deoxy- | [Molecular Formula]
C48H78O18 | [MDL Number]
MFCD09970961 | [MOL File]
139523-30-1.mol | [Molecular Weight]
943.12 |
| Chemical Properties | Back Directory | [Melting point ]
288-290℃ | [density ]
1.43±0.1 g/cm3 (20 ºC 760 Torr) | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
powder | [color ]
White |
| Hazard Information | Back Directory | [Uses]
Buddlejasaponin IV (BS‐IV) exerts anti-inflammatory and cytotoxic effects against cancer cells[1]. | [target]
P21 | Chk | Akt | PARP | Caspase | Bcl-2/Bax | p53 | NOS | COX | IL Receptor | TNF-α | NF-kB | MAPK | [References]
[1] Young Sun Hwang, et al. Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes. Phytother Res. 2011 Oct;25(10):1503-10. DOI:10.1002/ptr.3406
[2] Jong-Heon Won, et al. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation. Br J Pharmacol. 2006 May;148(2):216-25. DOI:10.1038/sj.bjp.0706718 |
|
|